Daily BriefsEvent-Driven

Daily Brief Event-Driven: China Traditional Chinese Medicine (570 HK): Relief as Update Favours the Bulls and more

In today’s briefing:

  • China Traditional Chinese Medicine (570 HK): Relief as Update Favours the Bulls
  • Examining the September Reshuffle of the KOSPI Size Index Series
  • TCM (570 HK): A Spoonful Of Sugar …
  • Midea Group (000333 CH): Index Implications at US$3bn Issue Size
  • Namoi Cotton (NAM AU): Louis Dreyfus Has This Stitched Up
  • Hankook Tire & Technology: M&A of Hanon System Falling Apart?
  • Porsche Automobile Holding: H1, Model Update, Discount to NAV


China Traditional Chinese Medicine (570 HK): Relief as Update Favours the Bulls

By Arun George

  • China Traditional Chinese Medicine (570 HK)’s monthly update reinforces the bull case. The gross spread has remained uncomfortably high since falling on no news on 26 June. 
  • The monthly update will relieve the bulls, as the consortium has finally made the regulatory submissions. The update stresses that the filing delay is due to an unwieldy consortium. 
  • Potential stumbling blocks remain, which should not be an issue. Nevertheless, the risk (17.7% downside to the undisturbed price)/reward (21.4% gross spread) remains attractive. 

Examining the September Reshuffle of the KOSPI Size Index Series

By Sanghyun Park

  • The September KOSPI Size Index rebalancing could bring back the typical price impacts seen over the past decade, unlike the March rebalancing.
  • The previous rebalancing had anomalies due to newly listed stocks in LARGE and a stronger downward trend in LARGE-to-MID transitions, disrupting the expected price impact.
  • For September’s rebalancing, fewer distortions are expected compared to March. The NPS Mid to Small Cap fund, a key influence, shows no significant changes in benchmark or AUM.

TCM (570 HK): A Spoonful Of Sugar …

By David Blennerhassett

  • A 14.8% gain month-to-date, including this past Monday’s 6.5% pop – you just knew something positive was taking place behind closed doors. And leaking its way into the public.   
  • So it was no real surprise to read in the latest monthly update announcement on the HKEx that various regulatory approvals are almost, but not quite, satisfied.
  • The wording in the announcement strikes a positive tone. Even remaining conservative on the timeline, this could be wrapped up before year-end. 

Midea Group (000333 CH): Index Implications at US$3bn Issue Size

By Brian Freitas

  • Midea Group Co Ltd A (000333 CH) has got approval to list on the HKEX (388 HK) and reports are that the listing could be up to US$3bn.
  • That issue size is around half of the maximum that the company can issue. But it would still need cornerstone investors and a nice discount on the H-shares.
  • The stock will still get included in some indices even with the scaled down size, and inclusion in Southbound Stock Connect is a given.

Namoi Cotton (NAM AU): Louis Dreyfus Has This Stitched Up

By David Blennerhassett

  • Since Louis Dreyfus Company (LDC) first announced a A$0.51/share Offer, by way of a Scheme, on the 28 November 2023, and Olam Agri countered, there have been significant developments. 
  • Both suitors have now tabled off-market Offers (A$0.67/share from LDC, and A$0.70/share from Olam Agri). Both Offers are open for tendering. Both have extended their closing dates numerous times.
  • And both suitors have also faced ACCC scrutiny. As of today, only LDC, currently holding a 20.2% stake in Namoi, is in the clear.

Hankook Tire & Technology: M&A of Hanon System Falling Apart?

By Douglas Kim

  • There are increasing signs that Hankook Tire & Technology’s M&A of Hanon Systems could be falling apart. 
  • The deadline for signing the main M&A contract to purchase a 25% stake in Hanon Systems has been postponed indefinitely.
  • New contingent liabilities at Hanon Systems have been uncovered during the 10 week due diligence process of Hanon Systems by Hankook T&T.

Porsche Automobile Holding: H1, Model Update, Discount to NAV

By Jesus Rodriguez Aguilar

  • Porsche SE is trading at a 35.3% discount to NAV, vs. 32.4% long-term average, implying a 68% probability that Porsche SE will be liable for c. €6.5 billion legal claims.
  • I think this is too harsh. Shares are trading at a Fwd P/E of 2.5x and a dividend yield of 7.8%, which I consider very attractive. 
  • Porsche SE presents an attractive opportunity to gain exposure to Volkswagen and Porsche AG. Porsche SE is focusing on deleveraging which should drive a reduction in the discount.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars